Trial Details
TERMINATEDBasic Information
| Clinical ID | c2931 |
|---|---|
| Identifier | NCT02768532 |
| Trial Title | Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Vedolizumab |
Participant Information
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
|---|---|
| City | Le Kremlin-Bicêtre |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2016-07-01 |
|---|---|
| Primary Completion Date | 2022-01-11 |
| Completion Date | 2023-01-23 |